Back
Reshape Lifesciences Stock Predictions
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
25
RSLS
Reshape Lifesciences
Last Price:
$6.01
Seasonality Move:
-18.69%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Reshape Lifesciences Stock Forecast
-
Over the next 52 weeks, Reshape Lifesciences has on average historically fallen by 34.6% based on the past 8 years of stock performance.
-
Reshape Lifesciences has fallen lower in 7 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%
-
Is Reshape Lifesciences Stock Undervalued?The current Reshape Lifesciences [RSLS] share price is $6.25. The Score for RSLS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
RSLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Reshape Lifesciences Stock Go Up Next Year?
-
Over the next 52 weeks, Reshape Lifesciences has on average historically fallen by 34.6% based on the past 8 years of stock performance.
Reshape Lifesciences Stock Rating
Sell
25
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences overpriced?
-
Reshape Lifesciences has fallen lower in 7 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 87.5%
Reshape Lifesciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
reshapelifesciences.com
52-Week Data
52-Week High:
725.02
52-Week Low:
5.53
Prediction Charts
Market Cap:
2.8M
Price in USD:
6.25
Volume:
86.1K
Beta:
0.41
Technical Analysis
SMA50:
12.93
SMA100:
50.27
SMA200:
115.20
52-Wk Change:
-97.42%
Stock Predictions
-
Is Reshape Lifesciences stock public?Yes, Reshape Lifesciences is a publicly traded company.
-
What is the Reshape Lifesciences stock quote today?The Reshape Lifesciences stock price is 6.25 USD today.
-
How to buy Reshape Lifesciences stock online?You can buy Reshape Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 9.72 | 9.50 | 10.21 | 9.38 |
| Apr-25 | 9.02 | 9.13 | 9.60 | 9.02 |
| Apr-28 | 9.25 | 9.05 | 9.55 | 8.87 |
| Apr-29 | 8.75 | 8.61 | 8.81 | 8.24 |
| Apr-30 | 8.50 | 8.46 | 8.63 | 8.13 |
| May-1 | 8.25 | 8.48 | 8.74 | 8.18 |
| May-2 | 13.72 | 10.50 | 14.10 | 9.76 |
| May-5 | 9.75 | 10.51 | 11.57 | 9.75 |
| May-6 | 10.05 | 11.13 | 11.65 | 10.05 |
| May-7 | 8.75 | 8.84 | 9.36 | 8.25 |
| May-8 | 8.54 | 8.33 | 8.58 | 8.13 |
| May-9 | 7.12 | 6.66 | 7.30 | 5.53 |
| May-12 | 5.67 | 6.01 | 6.25 | 5.64 |
| May-13 | 5.95 | 6.25 | 6.47 | 5.75 |
Reshape Lifesciences Earnings
Reshape Lifesciences Earnings Report: Per Share Reshape Lifesciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Reshape Lifesciences Forecast Revenue Growth
Reshape Lifesciences Stock Analysis: Historical quarterly revenues per share for Reshape Lifesciences and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.